Prevention of dementia should start 20 years before symptoms become apparent

被引：2

作者：

Diener, Hans-Christoph ^{[1
,2
]}

机构：

[1] Univ Hosp Essen, Dept Neurol, D-45147 Essen, Germany

[2] Univ Hosp Essen, Stroke Ctr, D-45147 Essen, Germany

来源：

EUROPEAN HEART JOURNAL | 2011年 / 32卷 / 18期

关键词：

ALZHEIMERS-DISEASE; COGNITIVE DECLINE; TRIAL; RISK; HYPERTENSION;

D O I：

10.1093/eurheartj/ehr122

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2228 / 2230

页数：3

共 13 条

[1] Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial:: a double-blind, active and placebo-controlled study [J].

Dienert, Hans-Christoph ;

Saccot, Ralph L. ;

Yusuft, Salim ;

Cotton, Daniel ;

Ounpuu, Stephanie ;

Lawton, William A. ;

Palesch, Yuko ;

Martin, Renee H. ;

Albers, Gregory W. ;

Bath, Philip ;

Bornstein, Natan ;

Chan, Bernard P. L. ;

Chen, Sien-Tsong ;

Cunha, Luis ;

Dahlof, Bjorn ;

De Keyser, Jacques ;

Donnan, Geoffrey A. ;

Estol, Conrado ;

Gorelick, Philip ;

Gu, Vivian ;

Hermansson, Karin ;

Hilbrich, Lutz ;

Kaste, Markku ;

Lu, Chuanzhen ;

Machnig, Thomas ;

Pais, Prem ;

Roberts, Robin ;

Skvortsova, Veronika ;

Teal, Philip ;

Toni, Danilo ;

VanderMaelen, Cam ;

Voigt, Thor ;

Weber, Michael ;

Yoon, Byung-Woo .

LANCET NEUROLOGY, 2008, 7 (10) :875-884

[2] Global prevalence of dementia: a Delphi consensus study [J].

Ferri, CP ;

Prince, M ;

Brayne, C ;

Brodaty, H ;

Fratiglioni, L ;

Ganguli, M ;

Hall, K ;

Hasegawa, K ;

Hendrie, H ;

Huang, YQ ;

Jorm, A ;

Mathers, C ;

Menezes, PR ;

Rimmer, E ;

Scazufca, M .

LANCET, 2005, 366 (9503) :2112-2117

[3] Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial [J].

Forette, F ;

Seux, ML ;

Staessen, JA ;

Thijs, L ;

Birkenhäger, WH ;

Babarskiene, MR ;

Babeanu, S ;

Bossini, A ;

Gil-Extremera, B ;

Girerd, X ;

Laks, T ;

Lilov, E ;

Moisseyev, V ;

Tuomilehto, J ;

Vanhanen, H ;

Webster, J ;

Yodfat, Y ;

Fagard, R .

LANCET, 1998, 352 (9137) :1347-1351

[4] Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease? [J].

Humpel, Christian .

EXPERIMENTAL GERONTOLOGY, 2011, 46 (04) :225-232

[5] Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II study [J].

Kaffashian, Sara ;

Dugravot, Aline ;

Nabi, Hermann ;

Batty, G. David ;

Brunner, Eric ;

Kivimaeki, Mika ;

Singh-Manoux, Archana .

EUROPEAN HEART JOURNAL, 2011, 32 (18) :2326-2332

[6] Alzheimer's disease - The ways of prevention [J].

Kivipelto, M. ;

Solomon, A. .

JOURNAL OF NUTRITION HEALTH & AGING, 2008, 12 (01) :89S-94S

[7] Determinants of vascular dementia in the Cardiovascular Health Cognition Study [J].

Kuller, LH ;

Lopez, OL ;

Jagust, WJ ;

Becker, JT ;

DeKosky, ST ;

Lyketsos, C ;

Kawas, C ;

Breitner, JCS ;

Fitzpatrick, A ;

Dulberg, C .

NEUROLOGY, 2005, 64 (09) :1548-1552

[8] Candesartan and cognitive decline in older patients with hypertension - A substudy of the SCOPE trial [J].

Saxby, B. K. ;

Harrington, F. ;

Wesnes, K. A. ;

McKeith, I. G. ;

Ford, G. A. .

NEUROLOGY, 2008, 70 (19) :1858-1866

[9] Where Vascular Meets Neurodegenerative Disease [J].

Schneider, Julie A. ;

Bennett, David A. .

STROKE, 2010, 41 (10) :S144-S146

[10] Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial [J].

Shepherd, J ;

Blauw, GJ ;

Murphy, MB ;

Bollen, ELEM ;

Buckley, BM ;

Cobbe, SM ;

Ford, I ;

Gaw, A ;

Hyland, M ;

Jukema, JW ;

Kamper, AM ;

Macfarlane, PW ;

Meinders, AE ;

Norrie, J ;

Packard, CJ ;

Perry, IJ ;

Stott, DJ ;

Sweeney, BJ ;

Twomey, C ;

Westendorp, RGJ .

LANCET, 2002, 360 (9346) :1623-1630

← 1 2 →